REGENXBIO, Inc. (RGNX)
10.33
+0.07
(+0.68%)
USD |
NASDAQ |
Feb 06, 16:00
10.30
-0.03
(-0.29%)
After-Hours: 20:00
REGENXBIO SG&A Expense (TTM) : 80.53M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Omeros Corp. | 44.20M |
| Sarepta Therapeutics, Inc. | 527.29M |
| AbbVie, Inc. | 14.01B |
| CytomX Therapeutics, Inc. | 28.10M |
| Krystal Biotech, Inc. | 136.75M |